3
Announcements
Trials
Browse
Landscape
Status
Completed
63
Terminated
24
Unknown
18
Recruiting
18
Not yet recruiting
4
Active not recruiting
4
Withdrawn
2
No longer available
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Leukemia, Myeloid, Acute
140
Leukemia
97
Leukemia, Lymphocytic, Chronic, B-Cell
96
Precursor Cell Lymphoblastic Leukemia-Lymphoma
90
Hematologic Neoplasms
69
Myelodysplastic Syndromes
55
Lymphoma
47
Lymphoma, Non-Hodgkin
45
Lymphoma, B-Cell, Marginal Zone
34
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
34
Lymphoma, Mantle-Cell
33
Lymphoma, Follicular
33
Burkitt Lymphoma
32
Recurrence
28
Lymphoma, Large B-Cell, Diffuse
28
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
24
Hodgkin Disease
23
Neoplasms
22
Leukemia, Myelomonocytic, Chronic
22
Multiple Myeloma
21
Myeloproliferative Disorders
20
Waldenstrom Macroglobulinemia
19
Lymphoma, Large-Cell, Immunoblastic
19
Leukemia, Myeloid, Chronic-Phase
17
Congenital Abnormalities
16
Primary Myelofibrosis
15
Leukemia, Myeloid, Accelerated Phase
14
Leukemia, Biphenotypic, Acute
14
Mycosis Fungoides
13
Lymphoma, T-Cell, Cutaneous
13
Interventions
Interviews as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
Leukemia, Myeloid
×
Other hematologic neoplasm
×
Clear all
NCT05309018
2024-05-23
LAMIPA
Centre Hospitalier Régional Metz-Thionville
Withdrawn
NCT04406207
2022-08-22
ERVAL
Hospices Civils de Lyon
Withdrawn